COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS

9 Months Ended

Mar. 31, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS

NOTE 4. COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS

Inventory

Inventory is stated at the lower of cost (first-in, first-out) or market and consists of the following (in thousands):

	March 31, 2017		June 30, 2016
Raw materials /purchased components	$	994	$	1,462
Work in process		957		818
Sub-assemblies /finished components		940		1,010
Finished goods		84		74
Total inventory	$	2,975	$	3,364

Investments

Investments are stated at market value and consist of the following (in thousands):

	March 31, 2017		June 30, 2016
Marketable equity securities	$	337	$	—

Investments at March 31, 2017 had an aggregate cost basis of $336,000 and gross unrealized gains of $1,000.

Intangibles

Intangibles consist of the following (in thousands):

	March 31, 2017			June 30, 2016
Capitalized software development costs	$	—		$	73
Covenant not to compete		52			52
Trade name		50			50
Customer list and backlog		167			316
Patent-related costs		141			121
Total intangibles	$	410		$	612
Less accumulated amortization		(90	)		(161	)
	$	320		$	451

Capitalized software development costs relate to internally developed software, which was fully amortized during fiscal 2016 and both the software development costs and corresponding accumulated amortization were offset during the first quarter of fiscal 2017. Both the covenant not to compete and the customer list and backlog relate to assets acquired in conjunction with the business acquisitions described in Note 2 above and are being amortized over various periods not to exceed ten years. The customer backlog has been fully amortized and both the cost and related accumulated amortization have been offset during the current fiscal year. During the first quarter of fiscal 2017, we recognized an impairment charge for the remaining un-amortized customer list related to the Huber business in the amount of $113,000, as we do not expect there to be any significant future cash flows resulting from these customer relationships and have written-off the cost basis and accumulated amortization during the current fiscal year. The trade name relates exclusively to Fineline and has an indefinite life, subject to impairment loss assessment annually, or more frequently if certain conditions exist. Patent-related costs consist of legal fees incurred in connection with both patent applications and a patent issuance, and will be amortized over the estimated life of the product(s) that is or will be utilizing the technology, or expensed immediately in the event the patent office denies the issuance of the patent. We anticipate recording amortization expense of approximately $12,000 in the remainder of fiscal 2017, $54,000 in each of fiscal 2018 and 2019, $49,000 in fiscal 2020, $44,000 in fiscal 2021, $34,000 in fiscal 2021 and the remaining $23,000 thereafter.